Price and states served both move. Read them off the seller's own site before you enroll.How our reviews work →

Corsica Health vs Hers

Corsica Health and Hers both sell semaglutide and tirzepatide; this is how their prices, coverage and records differ.

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

By Ruth Calder · Enforcement Editor
Editorially reviewed (not clinically reviewed). Not medical advice · How we verify contentLast reviewed
Corsica Health logo

Corsica Health

7.1
★★★★☆3.6/5

Best for: moving between compounded and brand without changing seller

Visit Corsica Health →
VS
Hers logo

Hers

6.6
★★★☆☆3.3/5

Best for: coverage in all 50 states, which most sellers will not confirm

Visit Hers →

If you are choosing between Corsica Health and Hers, price alone will not settle it. Both prescribe semaglutide and tirzepatide, so moving from one to the other would not change your drug. Corsica Health leads our six-part score, 7.1 to 6.6. One of the two has an FDA warning letter on record, covered below.

Corsica Health vs Hers price

Corsica Health and Hers start at the same figure, $199 a month, so the entry price does not separate them. Look at what each price covers and at the per-drug prices below.

Drug by drug: Semaglutide costs the same at both, $199 a month on a prepaid plan; tirzepatide is cheaper at Corsica Health ($249 a month on a prepaid plan vs $299 a month).

Medications and formats

Both sell semaglutide and tirzepatide.

On format they match: each offers compounded injections and brand-name pens.

Where each one treats patients

Corsica Health does not publish where it ships, and Hers lists 50 states.

Pricing

Corsica Health

Compounded semaglutide (3-month plan)Compounded
$199/mo
semaglutide

3-month plan: $597 upfront, 20% off

Compounded semaglutide (1-month plan)Compounded
$249/mo
semaglutide

1-month plan

Compounded tirzepatide (3-month plan)Compounded
$249/mo
tirzepatide

3-month plan: $747 upfront, 28% off

Compounded tirzepatide (1-month plan)Compounded
$349/mo
tirzepatide

1-month plan

Brand-name WegovyBrand-name
$1499/mo
Wegovy
Brand-name OzempicBrand-name
$1499/mo
Ozempic
Brand-name MounjaroBrand-name
$1499/mo
Mounjaro
Brand-name ZepboundBrand-name
$1499/mo
Zepbound

Hers

StartingCompounded
$199/mo
semaglutide
StartingBrand-name
$299/mo
tirzepatide

Brand Zepbound from $299/mo medication-only; requires Hers Weight Loss Membership ($149/mo)

What each price covers

Both prices cover the medication itself.

Corsica Health's price also covers the clinician visit and shipping, which Hers does not claim.

Corsica Health is silent on lab work and coaching.

Hers is silent on shipping and lab work.

Corsica Health

Covered by the monthly price

Medication

In the price

Clinician visits

In the price

Shipping

In the price

Lab work

Not stated

Coaching

Not stated

Hers

Covered by the monthly price

Medication

In the price

Clinician visits

Charged on top

Shipping

Not stated

Lab work

Not stated

Coaching

Charged on top

Where each one scores higher

Overall, Corsica Health scores 7.1 and Hers 6.6 out of 10.

Corsica Health is stronger on value (5.0 vs 3.0), trust & safety (6.5 vs 5.5) and support (7.0 vs 3.0).

Hers is stronger on accessibility (10.0 vs 5.0).

Effectiveness and user experience are within half a point.

How we score

Corsica Health

7.1/10

Overall

Hers

6.6/10

Value25%

5.0A
vs
B
3.0

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

8.0A
vs
B
8.0

Trust & Safety15%

6.5A
vs
B
5.5

Accessibility10%

5.0A
vs
B
10.0

Support10%

7.0A
vs
B
3.0

FDA warning letters

The FDA sent Hers a warning letter dated September 9, 2025 (letter 716825), and it is still open.

Corsica Health has no FDA warning letter on record with us.

Features & Coverage

FeatureCorsica HealthHers
Starting Price$199/mo prepaid$199/mo
Features✓8 features2 features
States AvailableNot disclosed50
Compounded✓ Yes✓ Yes
Brand Name✓ Yes✓ Yes
FSA/HSA Accepted——
FDA Warning Letters✓None1 letter

About Corsica Health

Corsica Health starts compounded semaglutide at $299/mo and compounded tirzepatide at $399/mo, and lists brand Ozempic, Wegovy and Mounjaro at $1,499/mo. Publishing compounded and brand SKUs side by side on one site is uncommon transparency. Patients move through a structured assessment, provider review and medication flow, and both compounded and brand-name FDA-approved injections are available.

Read our full Corsica Health review →

About Hers

Hers is the women-focused telehealth brand from Hims and Hers. It sells compounded semaglutide on a 6-month plan.

Read our full Hers review →

Pros & Cons

Corsica Health

What we like

  • Semaglutide costs $199 a month, close to the $185 median for compounded semaglutide across the sellers we compare
  • Tirzepatide costs $249 a month, close to the $250 median for compounded tirzepatide across the sellers we compare
  • Shows its price before the medical questionnaire, so you can compare it without handing over health information
  • The monthly price includes the medication, clinician visits and shipping
  • We found no FDA warning letters issued to Corsica Health

Watch-outs

  • Confirm it serves your state before you start the intake
  • Ask which pharmacy fills the prescription before you pay, so you can check its license
  • Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality

Hers

What we like

  • Shows its price before the medical questionnaire, so you can compare it without handing over health information
  • The monthly price includes the medication
  • Serves all 50 states

Watch-outs

  • Not included in the monthly price: clinician visits, coaching
  • Ask which pharmacy fills the prescription before you pay, so you can check its license
  • The FDA has issued Hers a warning letter. Read what it alleges: a letter flags a problem but does not by itself rule a seller out
  • Its semaglutide is compounded rather than FDA-approved, so it has not been reviewed by the agency for safety, effectiveness or manufacturing quality

Our Verdict

Winner: Corsica Health

Corsica Health wins this one, 7.1 to 6.6, above all for moving between compounded and brand without changing seller. Hers fits better if coverage in all 50 states, which most sellers will not confirm is your priority.

Choose Corsica Health if…

You want moving between compounded and brand without changing seller and an opening price near $199 a month.

Choose Hers if…

You want coverage in all 50 states, which most sellers will not confirm and an opening price near $199 a month.

Ready to start? GLP-1 providers we have vetted

Telehealth providers, vetted by us, prescribing GLP-1 online.

Vetted by our editors · no insurance required

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

9.0

bmiMD

Starting below a standard dose, with microdose tiers

6.7

RxSpan MD

Knowing which pharmacy fills the vial: it names Belmar Pharmacy

6.6

Luvo Health

Moving between compounded and brand without changing seller

Corsica Health vs Hers: FAQ

Neither on the entry price: Corsica Health and Hers both start at about $199 a month. The difference is in what the price includes.
Yes, both sell semaglutide and tirzepatide.
Corsica Health does not publish where it ships; Hers lists 50 states. Confirm your state before paying.
Both include the medication itself. Only Corsica Health includes the clinician visit and shipping.
Corsica Health has none. Hers has an open FDA warning letter from September 9, 2025.
No. Neither Corsica Health nor Hers pays us anything.

Or see the full category ranking.

Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.